After 20 years in academic research, Dr. Neal Amin left his Stanford faculty position to start Sculpta, a company pioneering a "Protein Sculpting" approach to treat neurodegenerative diseases.

Siolta Therapeutics vision was bold and prevention-focused: to prevent allergic diseases in infants before symptoms ever appear – not to manage them or treat them after diagnosis, but to stop them from developing in the first place. This year, that vision became reality.

Dr. Kristen Hege delivered a memorable keynote to our community, sharing wisdom gained from her transformative journey through academic medicine and biotech leadership.

The delegation was given an immersive tour of the facilities, showcasing cutting-edge laboratories, co-working spaces, and support services that MBC BioLabs offers to its resident companies.